Skip to main content
Premium Trial:

Request an Annual Quote

Angus MacLeod, David Della Penta

Premium

Galapagos said this week that Angus MacLeod has joined the company's service division BioFocus as director of medicinal chemistry.

MacLeod previously worked at Merck Sharp & Dohme, most recently as senior director of medicinal chemistry, Galapagos said.


Fisher Scientific said this week that President and CEO David Della Penta will retire at the end of 2006.

He has been with Fisher since 1998. The company said additional announcements regarding his successor will be made later in the year.

 

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.